Cargando…
Paternal use of medications for inflammatory bowel disease and the risk of hospital‐diagnosed infections in the offspring: a nationwide cohort study
BACKGROUND: Information regarding the impact of paternal inflammatory bowel disease (IBD) medications on child outcomes is scarce. AIM: To examine the risk of childhood infections associated with fathers' use of anti‐inflammatory/immunosuppressive medications taken before conception. METHODS: T...
Autores principales: | Friedman, Sonia, Garvik, Olav Sivertsen, Nielsen, Jan, Nørgård, Bente Mertz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542174/ https://www.ncbi.nlm.nih.gov/pubmed/35770457 http://dx.doi.org/10.1111/apt.17113 |
Ejemplares similares
-
The safety of paternal and maternal use of 5‐aminosalicylic acid during conception and pregnancy: a nationwide cohort study
por: Nørgård, Bente Mertz, et al.
Publicado: (2022) -
Antidepressant medication use in Inflammatory Bowel Disease: a nationally representative population‐based study
por: Jayasooriya, Nishani, et al.
Publicado: (2022) -
The inexorable increase of biologic exposure in paediatric inflammatory bowel disease: a Scottish, population‐based, longitudinal study
por: Burgess, Christopher J., et al.
Publicado: (2022) -
Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis
por: Mahadevan, Uma, et al.
Publicado: (2018) -
Mendelian Disease Associations Reveal Novel Insights into Inflammatory Bowel Disease
por: Han, Lichy, et al.
Publicado: (2018)